Mark Kaye - Mar 1, 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP & CFO
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 04:22 PM
Previous filing
Oct 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Award $0 +2.76K +13.59% $0.00 23K Mar 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +10.6K $0.00 10.6K Mar 1, 2024 Common Stock 10.6K $499.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share units. Restrictions lapse as follows: 918 shares each on 3/1/2025 and 3/1/2026 and 919 shares on 3/1/2027.
F2 The option represents a right to purchase a total of 10,633 shares, and is exercisable in two installments of 3,544 shares each, and one installment of 3,545 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.